Betty on the News: New Drug Could Help Smokers Quit for Good
If you’re trying to overcome your desire to smoke, then listen up!
The National Institute on Drug Abuse has given Nabi BioPharmaceuticals a $10 million grant to take an anti-nicotine vaccine to Phase III clinical trials, according to CNN.
NicVAX was created to help stimulate the immune system to generate antibodies that cling to nicotine in a smoker’s body and to prevent nicotine from entering the brain. Experts are hoping that the drug, which began to be tested last week, will make it easier for Americans to kick their desire to smoke.
“Nicotine addiction causes nearly a half-million deaths annually in the United States alone,” NIH Director Dr. Frances Collins disclosed. “Finding effective treatments that can help people stay off cigarettes has been a real challenge. This Phase III trial of a nicotine vaccine offers tremendous hope towards solving this immense public health problem.” (CNN)